Word

KAABEV

Status

Registered

Status Code

700

Status Date

Tuesday, March 16, 2021

Serial Number

88810003

Registration Number

6292214

Registration Date

Tuesday, March 16, 2021

Mark Type

4000

Filing Date

Tuesday, February 25, 2020

Published for Opposition

Tuesday, December 29, 2020

Trademark Owner History

Glaxo Group Limited - Original Registrant

Classifications

5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events

Nov 8, 2022

Applicant/Correspondence Changes (Non-Responsive) Entered

Nov 8, 2022

Teas Change Of Correspondence Received

Nov 8, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Nov 8, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Nov 8, 2022

Teas Change Of Owner Address Received

Mar 16, 2021

Registered-Principal Register

Dec 29, 2020

Official Gazette Publication Confirmation E-Mailed

Dec 29, 2020

Published For Opposition

Dec 9, 2020

Notification Of Notice Of Publication E-Mailed

Nov 24, 2020

Approved For Pub - Principal Register

Oct 23, 2020

Teas/Email Correspondence Entered

Oct 22, 2020

Correspondence Received In Law Office

Oct 22, 2020

Teas Response To Office Action Received

Apr 22, 2020

Notification Of Non-Final Action E-Mailed

Apr 22, 2020

Non-Final Action E-Mailed

Apr 22, 2020

Non-Final Action Written

Mar 3, 2020

Assigned To Examiner

Feb 28, 2020

New Application Office Supplied Data Entered In Tram

Feb 28, 2020

New Application Entered In Tram